HALO:BMV
Halozyme Therapeutics, Inc.
MX$1,740.00
0.00%
(0.00) 1D
Aug 17, 10:38:44 AM GMT-6 · MXN
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HALO...
Mkt. cap
12.51B
Avg. vol.
46.00
Volume
0.00
52-wk high
MX$1,759.00
52-wk low
MX$1,121.86
No. of employees
423
Mkt. cap
12.51B
Avg. vol.
46.00
Volume
0.00
52-wk high
MX$1,759.00
52-wk low
MX$1,121.86
No. of employees
423
News stories
From web sources and news partners
RTTNews
·
10 hours ago
Biotech Stocks At 52-Week Highs - ATTO, HALO, IKT, TVTX, ATRC
Investing.com
·
1 day ago
H.C. Wainwright reiterates Halozyme stock rating on deal momentum
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOHelen I. Torley
Employees423
Founded1998
HeadquartersSan Diego, California, United States
SectorBiotechnology
Websitehalozyme.com